InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Tanen David M. Director active across 2 companies, notably Arno Therapeutics, Inc. Cumulatively, 2 disclosures have been recorded. Split: 1 buy · 0 sell. History available since 20 June 2025. The latest transaction was disclosed on 20 June 2025 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条